Regulatory and Global Challenges in the Approval, Accessibility, and Monitoring of mRNA Vaccines Post COVID-19: A Review
Journal of Regulatory Science · 18.12.2025 · 13 (1)
DOI: 10.21423/jrs.regsci.131305 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Regulatory Science, online erschienen am 18.12.2025. Verfasst von Dr. Drashti Shukla und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
An important advancement in vaccine technology was made possible by the COVID-19 pandemic, which sped up the creation and regulatory licensing of mRNA vaccines. The regulatory obstacles faced in the post-pandemic era during the approval, monitoring, and post-market surveillance of mRNA vaccines are examined in this paper. Emergency usage permits allowed for quick implementation, but long-term safety, public confidence, and worldwide accessibility are still major issues. To strike a balance between quick approvals and thorough safety evaluations, regulatory bodies including the FDA, EMA, and WHO have modified their frameworks. Despite persistent under reporting and inconsistent data, post- market surveillance systems such as VAERS and EudraVigilance have been crucial in detecting adverse occurrences. In order to guarantee fair vaccine access, expedite approval procedures, and fortify pharmacovigilance infrastructure, the a assessment also examines the necessity of international regulatory harmonization. Regulatory futures approaches must integrate real-time data monitoring, adaptive approval pathways, and international cooperation to enhance preparedness for future pandemics while maintaining public confidence in vaccine safety and efficacy.
Zitieren
APA
Shukla, D. D., & Vora, D. (2025). Regulatory and Global Challenges in the Approval, Accessibility, and Monitoring of mRNA Vaccines Post COVID-19: A Review. Journal of Regulatory Science, 13(1). https://doi.org/10.21423/jrs.regsci.131305
Vancouver
Shukla DD, Vora D. Regulatory and Global Challenges in the Approval, Accessibility, and Monitoring of mRNA Vaccines Post COVID-19: A Review. Journal of Regulatory Science. 2025;13(1). doi:10.21423/jrs.regsci.131305
BibTeX
@article{Shukla2025,
author = {Shukla, Dr. Drashti and Vora, Dr.Kunal},
title = {Regulatory and Global Challenges in the Approval, Accessibility, and Monitoring of mRNA Vaccines Post COVID-19: A Review},
journal = {Journal of Regulatory Science},
year = {2025},
volume = {13},
number = {1},
doi = {10.21423/jrs.regsci.131305}
}
EUVIMED